Aster DM Healthcare Ltd is one of India’s leading healthcare service providers, known for its multi-specialty hospitals, clinics, and pharmacies across India and the Middle East. The company has earned strong investor confidence due to its steady growth, strong financial performance, and expanding healthcare network. In this article, we’ll discuss Aster DM Healthcare Ltd’s share price target from 2025 to 2030, its current performance, and future growth outlook.
Let’s dive into the company’s fundamentals, shareholding pattern, and year-wise price forecast.
Detail | Value |
---|---|
Open | ₹675.00 |
Previous Close | ₹672.55 |
High | ₹679.70 |
Low | ₹657.20 |
Volume | 1,141,275 |
Value (Lacs) | ₹7,550.68 |
VWAP | ₹669.94 |
Beta (Volatility) | 0.53 |
Market Capitalization | ₹34,278 Cr |
UC Limit | ₹807.05 |
LC Limit | ₹538.05 |
52-Week High | ₹679.70 |
52-Week Low | ₹387.10 |
Face Value | ₹10 |
All-Time High | ₹679.70 |
All-Time Low | ₹78.00 |
20D Avg Volume | 806,685 |
20D Avg Delivery (%) | 54.87% |
Book Value Per Share | ₹66.67 |
Dividend Yield | 0.76% |
Founded by Dr. Azad Moopen, Aster DM Healthcare is a prominent player in the healthcare sector, with a presence in India, the UAE, Oman, and Qatar. The company operates through hospitals, clinics, and retail pharmacies under brands like Aster, Medcare, and Access.
Aster DM Healthcare’s focus on quality medical care, expansion in Tier-II and Tier-III Indian cities, and investment in digital healthcare have made it one of the most promising healthcare stocks listed on the NSE and BSE.
Operates 33 hospitals and over 500 pharmacies across multiple geographies
Strong brand presence in India and the Middle East
Stable financial performance and consistent revenue growth
Focused on telemedicine and digital health solutions
Strong corporate governance and promoter leadership
Diversified revenue base — domestic and international
Investor Type | Holding (%) |
---|---|
Promoters | 40.39% |
Mutual Funds | 23.87% |
Foreign Institutions | 19.64% |
Retail & Others | 14.69% |
Other Domestic Institutions | 1.42% |
This diversified shareholding structure reflects strong institutional trust and retail investor participation.
Year | Minimum Target (₹) | Maximum Target (₹) |
---|---|---|
2025 | 690 | 720 |
2026 | 740 | 790 |
2027 | 810 | 880 |
2028 | 900 | 975 |
2029 | 1000 | 1100 |
2030 | 1150 | 1250 |
These targets are based on technical indicators, earnings growth projections, market expansion, and the company’s operational performance in India and the GCC region.
By 2025, Aster DM Healthcare is expected to sustain its growth momentum due to the strong demand for hospital services and expansion into secondary cities.
Why:
Rising healthcare spending in India and the Middle East
Growing demand for specialty and digital healthcare
Stable margins and efficient cost management
Investment Advice: Investors can consider buying on dips, as the stock shows solid fundamentals and low volatility (Beta 0.53).
In 2026, the company’s share price could strengthen further as healthcare infrastructure expands across its network.
Why:
New hospital openings and strategic tie-ups
Increasing contribution from Middle East operations
Improved patient volume and revenue per bed
Investment Advice: Long-term investors should continue holding; Aster is a defensive stock with steady returns and dividend potential.
By 2027, Aster DM Healthcare’s digital initiatives and new clinical services are expected to enhance profitability.
Why:
Digital healthcare (telemedicine, e-pharmacy) expansion
Growing medical tourism revenue
Improved EBITDA margin due to better cost optimization
Investment Advice: Ideal for SIP investors looking for consistent compounding and stability.
The company’s robust financial health and diversification should reflect positively in its market valuation by 2028.
Why:
Strengthened balance sheet with reduced debt
Expansion of Aster Labs and diagnostic services
Strong brand recognition and patient loyalty
Investment Advice: Continue investing for long-term wealth creation.
By 2029, Aster could benefit from international growth and strong hospital occupancy rates.
Why:
Strategic acquisitions in healthcare markets
Increase in operational efficiency
Enhanced shareholder returns through dividends
Investment Advice: Ideal for medium- to long-term investors seeking portfolio stability and growth.
By 2030, Aster DM Healthcare could establish itself as one of Asia’s most respected healthcare brands.
Why:
Dominance in India and GCC healthcare markets
Consistent profit growth and brand expansion
Integration of AI and digital diagnostics in operations
Investment Advice: Excellent choice for long-term investors looking for steady compounding and defensive sector exposure.
Yes. Aster DM Healthcare Ltd offers a strong long-term investment opportunity due to its consistent growth, strong management, and diversified operations.
Leading healthcare provider in India and GCC
Steady revenue and profit growth
Consistent dividend payout (0.76% yield)
Low volatility and strong institutional support
Healthcare sector resilience even in economic downturns
Currency fluctuations due to Middle East exposure
Regulatory changes in healthcare pricing
High competition in hospital and pharmacy space
Always consult a certified financial advisor before making investment decisions.
Aster DM Healthcare Ltd has emerged as one of the most trusted names in India’s healthcare industry. With its strong presence in the Middle East and India, consistent financial performance, and focus on digital expansion, the company is well-positioned for long-term growth.
Currently, the share price hovers around ₹675, close to its 52-week high of ₹679.70. Based on performance trends and expansion plans, analysts expect Aster DM Healthcare’s share price to potentially reach ₹1250 by 2030.
For investors seeking stable returns, consistent growth, and defensive exposure in the healthcare sector, Aster DM Healthcare Ltd could be a solid addition to their portfolio.
What is the current share price of Aster DM Healthcare Ltd?
As of October 2025, Aster DM Healthcare’s share price is around ₹675.
What is the 52-week high and low of Aster DM Healthcare?
The 52-week high is ₹679.70, and the 52-week low is ₹387.10.
Is Aster DM Healthcare a good long-term investment?
Yes, it’s a fundamentally strong stock in a growing sector with consistent profitability.
What is the face value of Aster DM Healthcare shares?
The face value of each share is ₹10.
What is the dividend yield of Aster DM Healthcare?
The company offers a dividend yield of approximately 0.76%.
Who are the major shareholders of Aster DM Healthcare?
Promoters hold 40.39%, followed by Mutual Funds at 23.87% and FIIs at 19.64%.
What is the market capitalization of Aster DM Healthcare?
The current market cap stands at around ₹34,278 crore.
Does Aster DM Healthcare have a presence outside India?
Yes, the company operates hospitals and clinics across the UAE, Oman, and Qatar.
What is Aster DM Healthcare’s share price target for 2030?
The projected share price target for 2030 is between ₹1150 and ₹1250.
Is it the right time to buy Aster DM Healthcare shares?
Considering its strong fundamentals and sector outlook, investors can consider accumulating the stock for long-term growth.
Disclaimer: This article is for educational purposes only. Investors should consult a registered financial advisor before making investment decisions.